415 Capital

Get funding

For over 25 years 415 Capital has been working with exceptional MedTech entrepreneurs to bring medical innovation to patients.

Use:
Date closing: -
Amount: 4M € - 8.0M €
Industry focus: Health;
Total budget: -
Entity type: Private Equity Firm
Vertical focus: All
Website: https://www.415capital.com/

Status:
Open
Funding type: Equity investment;
Geographic focus: Europe; Israel; United States of America;
Public/Private: Private
Stage focus:
Applicant target: Startup;

Add a Review Send question

Overview

415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.

They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcare system.

They are investors AND entrepreneurs: As investors, they have funded 45 MedTech companies in the past 28 years. As entrepreneurs, they have founded, built, and exited several successful European MedTech distribution companies.

Their ticket size ranges from €4-8M per company.

Applicants willing to get in touch with 415 Capital can do it by following this link.

Portfolio: Supira, R3 Vascular, Aktiia, Tricares.

Last updated on 2023-05-17 10:50